{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT03256370",
      "orgStudyIdInfo": {
        "id": "HMOs"
      },
      "organization": {
        "fullName": "Chulalongkorn University",
        "class": "OTHER"
      },
      "briefTitle": "Association of HMOs and Allergic Manifestations",
      "officialTitle": "The Association Between Human Milk Oligosaccharide and Development of Allergic Manifestations in Infants"
    },
    "statusModule": {
      "statusVerifiedDate": "2017-04",
      "overallStatus": "UNKNOWN",
      "lastKnownStatus": "RECRUITING",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2017-11-01",
        "type": "ESTIMATED"
      },
      "primaryCompletionDateStruct": {
        "date": "2018-10-05",
        "type": "ESTIMATED"
      },
      "completionDateStruct": {
        "date": "2019-10-05",
        "type": "ESTIMATED"
      },
      "studyFirstSubmitDate": "2017-08-11",
      "studyFirstSubmitQcDate": "2017-08-17",
      "studyFirstPostDateStruct": {
        "date": "2017-08-22",
        "type": "ACTUAL"
      },
      "lastUpdateSubmitDate": "2017-10-15",
      "lastUpdatePostDateStruct": {
        "date": "2017-10-17",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "Chulalongkorn University",
        "class": "OTHER"
      }
    },
    "descriptionModule": {
      "briefSummary": "Compare the HMO composition in breast milk of infants with allergic manifestation (atopic dermatitis and food allergy) in the first 3 years of life, healthy infants with allergic mother and healthy infants with non-allergic mother.",
      "detailedDescription": "* Parents of breast-fed infant from general pediatric clinic and allergy clinic of King Chulalongkorn Memorial Hospital were approached for informed about the research and ask to join this project\n* After completed informed consent, demographic data was collected and filled in case record form\n* Milk of mother in both allergic and control groups were collected 60 ml then transferred to freeze at -80oc to for human milk oligosaccharide analysis"
    },
    "conditionsModule": {
      "conditions": [
        "Human Milk Oligosaccharides, Allergic Manifestation"
      ],
      "keywords": [
        "Allergic manifestation, Human milk oligosaccharides, Breast Milk"
      ]
    },
    "designModule": {
      "studyType": "OBSERVATIONAL",
      "patientRegistry": false,
      "designInfo": {
        "observationalModel": "CASE_CONTROL",
        "timePerspective": "PROSPECTIVE"
      },
      "bioSpec": {
        "retention": "SAMPLES_WITHOUT_DNA",
        "description": "human breast-milk"
      },
      "enrollmentInfo": {
        "count": 150,
        "type": "ESTIMATED"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "Infants with allergic diseases",
          "description": "allergic disease : atopic dermatitis or food allergy",
          "interventionNames": [
            "Procedure: milk collection"
          ]
        },
        {
          "label": "Healthy infants with atopic mothers",
          "description": "atopic mothers : mothers with asthma or allergic rhinitis or allergic dermatitis (diagnosed by doctors)",
          "interventionNames": [
            "Procedure: milk collection"
          ]
        },
        {
          "label": "Healthy infants with non-atopic mothers.",
          "description": "non-atopic mothers : mothers without history of asthma or allergic rhinitis or allergic dermatitis",
          "interventionNames": [
            "Procedure: milk collection"
          ]
        }
      ],
      "interventions": [
        {
          "type": "PROCEDURE",
          "name": "milk collection",
          "description": "* Parents of breast-fed infant from general pediatric clinic and allergy clinic of King Chulalongkorn Memorial Hospital were approached for informed about the research and ask to join this project\n* After completed informed consent, demographic data was collected and filled in case record form\n* Milk of mother in both allergic and control groups were collected 60 ml then transferred to freeze at -80oc to for human milk oligosaccharide analysis\n\nMethod of human milk oligosaccharide analysis :\n\n1. Ultra High Pressure Liquid Chromatography(UHPLC) with fluorescence method\n2. High-Performance Anion-Exchange Chromatography with Pulsed Amperometric Detection (HPAEC-PAD) method",
          "armGroupLabels": [
            "Healthy infants with atopic mothers",
            "Healthy infants with non-atopic mothers.",
            "Infants with allergic diseases"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Atopic dermatitis",
          "description": "Relapsing eczematous typical morphology on typical distribution (Scalp, face, neck, and extensor surfaces of the skin) Typical morphology Acute and subacute : erythematous papules and plaques, may vesiculate and become exudative Chronic : lichenification, papules and excoriations",
          "timeFrame": "first 2 years of life"
        },
        {
          "measure": "IgE mediated food allergy",
          "description": "confirmed by oral food challenge",
          "timeFrame": "first 2 years of life"
        },
        {
          "measure": "Non-IgE mediated food allergy",
          "description": "Presentation of clinical ex. bloody stool when repeating episode occurred with the same food more than twice. Improvement of symptom after eliminating of suspected food",
          "timeFrame": "first 2 years of life"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n1. mothers with breast-fed infant with or without allergic manifestation\n2. Intend to participate for follow up and sign consent to participate in the study\n\nExclusion Criteria:\n\n1. Mothers with any medical illness or high risk infant pregnant\n2. Infants with disease which affected allergic disease\n3. No inform consent\n4. Anything in the opinion of the investigator that would prevent children from completing the study",
      "healthyVolunteers": true,
      "sex": "ALL",
      "maximumAge": "2 Years",
      "stdAges": [
        "CHILD"
      ],
      "studyPopulation": "Normal term children (born after 37 weeks gestation) from low risk healthy pregnant women aged 18-40 years divided to 3 groups i. Allergic groups : infants with allergic manifestation ii. High risk control groups : atopic mother with infant no disease iii. Healthy control groups : non- atopic mother with infant no disease",
      "samplingMethod": "PROBABILITY_SAMPLE"
    },
    "contactsLocationsModule": {
      "centralContacts": [
        {
          "name": "Narissara Suratannon, MD",
          "role": "CONTACT",
          "phone": "662-256-4933",
          "email": "narissara.su@chula.ac.th"
        },
        {
          "name": "Jintana Chataroopwijit, MD",
          "role": "CONTACT",
          "email": "Drjintana43@hotmail.com"
        }
      ],
      "locations": [
        {
          "facility": "Chulalongkorn University",
          "status": "RECRUITING",
          "city": "Pathum Wan",
          "state": "Bangkok",
          "zip": "10330",
          "country": "Thailand",
          "contacts": [
            {
              "name": "Narissara Suratannon, MD",
              "role": "CONTACT",
              "phone": "668-1295-0190",
              "email": "narissara.su@chula.ac.th"
            }
          ],
          "geoPoint": {
            "lat": 13.73649,
            "lon": 100.5239
          }
        }
      ]
    },
    "ipdSharingStatementModule": {
      "ipdSharing": "UNDECIDED"
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    }
  },
  "hasResults": false
}